Brainsway offers its Deep TMS technology for depressive disorders — the stock could be ready to break out from the base to a new high!

I would like to draw attention to Brainsway. The company, based in Israel, specializes in non-invasive neurostimulation treatments for mental disorders, among others, in the United States and East Asia. It offers the Deep TMS technology (Deep Transcranial Magnetic Stimulation) for the treatment of major depressive disorders, anxiety depression, bipolar disorders, and post-traumatic stress disorders. On December 12, the company announced positive pilot data from an independent, third-party study at Stanford University, which investigated an accelerated...